WORLDCOIN-FOUNDATION
13.12.2023 16:03:32 CET | Business Wire | Press release
Worldcoin today introduced a protocol update - World ID 2.0, a more powerful, privacy preserving “humanness” digital passport equipped with exciting app integrations* and a suite of new features. Humanness verification services are expanding in Mexico and Singapore, increasing global access to World ID 2.0.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231213314816/en/
The World ID 2.0 Passport. (Photo: Business Wire)
World ID 2.0 makes it easier to distinguish between bots and verified humans online while preserving privacy with popular apps and services with new pre-built integrations. The protocol will be integrated with popular e-commerce, gaming and social media platforms including: Shopify, Mercado Libre, Minecraft, Reddit and Telegram.
Prove personhood, not identity
The rapid global advancement of artificial intelligence has accelerated the need to differentiate between human- and AI-generated content online. As reported by CNBC, retailers are losing an estimated $100 billion per year from return fraud, bots and coupon stacking. Meanwhile, the digital gaming industry struggles to combat bots impacting the real number of humans playing online and have been alleged to fraudulently beat humans in competitive games.
World ID aims to provide a decentralized digital identity layer that enables anonymous actions for the benefit of every unique human online. With the humanness digital passport, individuals can verify to an app or service that they are human without disclosing their identity, and brands can ensure that their offerings and services are being used as intended. World ID 2.0 also offers new verification levels to provide developers choice when implementing humanness verification requirements into their apps or services.
App integrations deliver greater utility
Users and businesses benefit from World ID. New integrations with apps like Shopify, Telegram, Minecraft, Reddit and Mercado Libre, alongside existing integrations with apps including Discord, Talent Protocol and Okta’s Auth0, mean individuals can quickly and easily verify their humanness on the platforms they use every day. And with a new, high-performance developer platform enabling builders to easily integrate “Sign in with World ID” onto their app, new integrations are being added every week, all visible on the new Worldcoin App Store.
New verification levels offer increased access and flexibility
Nearly five million people globally now have a World ID, and more than 2.5 million have verified their humanness at an Orb so they can fully utilize their World ID.
With its new verification levels, World ID 2.0 introduces more ways for people to use their World ID based on the security needs of the application and to ensure individuals are not sharing more information than they need or want for a given application. From device verification for high convenience and accessibility all the way to Orb verification with additional face authentication for high security use cases, there’s now a way for everyone to use their World ID even if they haven’t yet had the opportunity to verify at an Orb.
How to get a World ID
Obtaining a World ID is as simple as downloading a compatible wallet, starting with the World App which is designed to support 94.5% of the iOS and 98.2% of Android smartphones in use today. Initial verification of a World ID offers a baseline level of protection with Device Auth and an Orb-verified World ID provides enhanced utility for applications or services requiring higher security and verification. Visit https://worldcoin.org/find-orb or check the World App to find an Orb verification location near you.
A look at Worldcoin momentum and expansion
Interest in access to Worldcoin and proof of personhood technologies like World ID is continuing to grow globally. In 2023, World ID verifications jumped from under a million in January to more than 2.5 million by the end of November. Additional Orb locations are also opening in both new and existing cities to help make sure everyone who wants to be a part of the Worldcoin community can do so. Mexico and Singapore join the list of locations where individuals can now find Orbs.
About the Worldcoin Foundation
The Worldcoin Foundation, a steward of the Worldcoin protocol until it is self-sufficient, aims to realize more inclusive, fair and just institutions of governance and of the global digital economy.
About the Worldcoin Protocol
The Worldcoin protocol is intended to be the world’s largest, most inclusive identity and financial public utility and to be accessible by everyone. Worldcoin was originally conceived by Sam Altman, Alex Blania and Max Novendstern. The Worldcoin protocol is designed to empower individuals and organizations around the world with the tools they need to participate in the digital economy and advance humanity's progress. Find out more about Worldcoin at www.worldcoin.org, on Twitter/X, Discord, YouTube and Telegram.
*World ID integrations do not imply World ID is an official product, or a partnership, sponsorship, or endorsement, of the companies whose products were integrated, such as Discord, Mercado Libre, Microsoft, Mojang, Reddit, and Shopify.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231213314816/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom